Supreme Court Decision Shakes Up Purdue Pharma’s Bankruptcy Strategy, Impacting Future Mass Tort Litigations
Washington, D.C. — The UXPreme Court has recently handed down a decision regarding Purdue Pharma’s bankruptcy strategy that stands to influence future legal strategies of companies embroiled in mass tort litigations. This ruling is a key development, coming amidst a noted uptick in multidistrict litigation cases, which are increasingly constituting a significant portion of the federal civil docket. Purdue Pharma, known for its production of OxyContin, has been at the center of a national controversy surrounding the opioid crisis in the United States. The firm sought bankruptcy protection as a mechanism to settle thousands of … Read more